Burgstahler David F

Venture Investor/General Partner at RVL Pharmaceuticals plc; Director at LNTH; Director, 10% owner at ANGO

Sold, on record
$258M
Dollars the filings state
Form 4 sales
12
Latest Sep 7, 2017
Form 144 notices
2
Proposed sales
Companies
3
Filed as an executive or holder

Companies

Sales by reason

0
Routine
0
Plan not stated
0
No plan
0
Unusual
Stacked: routine sales under a plan, sales whose filing does not state a plan, sales with no plan, and unusual sales.

Form 4 sales per month, last 12 months.

Sales chart range

Sales by company

Shares sold, every Form 4 sale on record.

Timeline

  1. 1 Form 4 sale LNTHUnusual
    Jun 20, 2017 2017

    Sold 3M shares at $14.87 ($44.6M)

    Burgstahler David F, Director, 10% owner

    Sold 63% of holdings ($70.8M position)1.8M shares left1x usual sizeFiling

  2. 2 Form 4 sale LNTHUnusual
    Aug 16, 2017 +57 days

    Sold 140,846 shares at $17.27 ($2.4M)

    Burgstahler David F, Director

    Sold 53.5% of holdings ($4.5M position)122,492 shares left0x usual sizeFiling

  3. 3 Form 4 sale LNTHUnusual
    Aug 28, 2017 +12 days

    Sold 91,166 shares at $17.01 ($1.6M)

    Burgstahler David F, Director

    Sold 48.3% of holdings ($3.2M position)97,479 shares left0x usual sizeFiling

  4. 4 Form 4 sale LNTHUnusual
    Aug 31, 2017 +3 days

    Sold 230,685 shares at $17.25 ($4M)

    Burgstahler David F, Director

    Sold 77.9% of holdings ($5.1M position)65,263 shares left0.1x usual sizeFiling

  5. 5 Form 4 sale LNTHUnusual
    Sep 6, 2017 +6 days

    Sold 78,833 shares at $16.95 ($1.3M)

    Burgstahler David F, Director

    Sold 59.9% of holdings ($2.2M position)52,684 shares left0x usual sizeFiling

  6. 6 Form 4 sale LNTHUnusual
    Sep 7, 2017 +1 day

    Sold 102,958 shares at $16.56 ($1.7M)

    Burgstahler David F, Director

    Sold 72.9% of holdings ($2.3M position)38,269 shares left0.1x usual sizeFiling

  7. 7 Form 144 notice RVL Pharmaceuticals plcNotice
    Aug 24, 2023 +2177 days

    Filed to sell 767,515 shares ($106k)

    Burgstahler David F, Venture Investor/General Partner

    No 10b5-1 planFirst sale on recordFiling

  8. 8 Form 144 notice RVL Pharmaceuticals plcNotice
    Sep 25, 2023 +32 days

    Filed to sell 670,694 shares ($60k)

    Burgstahler David F, Venture Investor/General Partner

    No 10b5-1 planFirst sale on recordFiling

Every transaction

Loading transactions…

Sales and notices (14)

Form 144 notices and Form 4 sales by Burgstahler David F
Source
Sep 25, 2023Sep 25, 2023RVL Pharmaceuticals plcVenture Investor/General PartnerForm 144 notice670,694$60kNoticeSEC
Aug 24, 2023Aug 24, 2023RVL Pharmaceuticals plcVenture Investor/General PartnerForm 144 notice767,515$106kNoticeSEC
Sep 7, 2017Sep 11, 2017LNTHDirectorForm 4 sale102,958$1.7M72.9%UnusualSEC
Sep 6, 2017Sep 6, 2017LNTHDirectorForm 4 sale78,833$1.3M59.9%UnusualSEC
Aug 31, 2017Aug 31, 2017LNTHDirectorForm 4 sale230,685$4M77.9%UnusualSEC
Aug 28, 2017Aug 28, 2017LNTHDirectorForm 4 sale91,166$1.6M48.3%UnusualSEC
Aug 16, 2017Aug 16, 2017LNTHDirectorForm 4 sale140,846$2.4M53.5%UnusualSEC
Jun 20, 2017Jun 22, 2017LNTHDirector, 10% ownerForm 4 sale3M$44.6M63.0%UnusualSEC
May 9, 2017May 11, 2017LNTHDirector, 10% ownerForm 4 sale3M$40.2M53.6%UnusualSEC
Apr 12, 2017Apr 14, 2017ANGODirector, 10% ownerForm 4 sale2.4M$37.6M86.0%UnusualSEC
Mar 17, 2017Mar 21, 2017LNTHDirector, 10% ownerForm 4 sale3M$36.6M46.6%UnusualSEC
Nov 21, 2016Nov 23, 2016LNTHDirector, 10% ownerForm 4 sale2.5M$22.5M36.9%UnusualSEC
Nov 18, 2016Nov 22, 2016ANGODirector, 10% ownerForm 4 sale2.1M$32.8M67.3%UnusualSEC
Aug 5, 2016Aug 5, 2016ANGODirector, 10% ownerForm 4 sale2.3M$32.9M59.1%UnusualSEC